OR WAIT null SECS
August 02, 2006
Contract service providers should be concerned about the market perceptions of their performance.
August 01, 2006
The principal objective of the annual PharmSource–Pharmaceutical Technology outsourcing survey is to gauge overall business trends in the contract manufacturing and research businesses. This year's edition documents an industry that is in good health but facing a new set of dynamics.
July 02, 2006
Pharmaceutical Technology provides perspective on pharmaceutical manufacturing activity, assessing the product portfolios, prescription volumes, revenues, and capital spending plans of more than 500 drug-makers. Novartis leads in diversity, with 889 products; Pfizer leads in number of scrips (352 million) and revenue ($44 billion). And generics companies are coming up on the inside.
June 02, 2006
The laboratory supplier landscape is undergoing a radical makeover.
February 24, 2006
Cambrex Reports Loss; Advances Biosciences Business
January 01, 2006
The big question for pharmaceutical services providers coming into 2006 is: will the good times continue to roll?
December 02, 2005
From politics to paychecks and downsizings to deadlines-what it's like to work for one of the world's largest industries.
November 23, 2005
Pfizer to Shut Parsippany Plant
November 07, 2005
Contract services providers gained a valuable look into major market conditions, offshoring trends, and 2006 growth opportunities during a morning presentation entitled "CMC Sourcing in transition: Consolidation, Offshoring, and the Market Outlook," presented by Jim Miller. Miller is president of PharmSource (Springfield, VA, www.pharmsource.com), publisher of the Bio/Pharmaceutical Outsourcing , and contributing editor of Pharmaceutical Technology.
November 03, 2005
Roche Puts Hold on Tamiflu in US